ISRCTN31291803已完成未知

Monitoring of Anti-Malarial Drug resistance by real-time quantitative nucleic acid sequence-based amplification and the impact on TRANSmission of Plasmodium falciparum

The Netherlands Foundation for the Advancement of Tropical Research (NWO-WOTRO) (The Netherlands)0 个研究点目标入组 500 人开始时间: 2007年3月27日最近更新: 2021年9月7日

适应症

试验速览

暂无简介。

•1. Age six months to ten years
•2. Residents of research area, able to come for complete schedule of follow-up
•3. Diagnosed with uncomplicated malaria, Plasmodium falciparum or P. falciparum and P. malariae double infection
•4. Parasitaemia 1000 to 100,000 P. falciparum P/ul (Giemsa-stained blood smears counted against 200 White Blood Cells (WBC), negative result if 100 parasite negative microscopic fields)
•5. Temperature more than 37.5°C and less than 39.5°C, or a history of fever in the previous 24 hours
•6. No history of adverse reactions to Sulphadoxine-Pyrimethamine (SP) treatment
•7. Understanding of the procedures of the study by parent or guardian and willing to participate (informed consent signed)

•1. General danger signs of severe malaria or Haemoglobin (Hb) count more than 5 gm/dl
•2. Severe malnutrition
•3. Presence of diseases other than malaria causing febrile conditions
•4. Unwilling to participate and sign informed consent forms

发起方

The Netherlands Foundation for the Advancement of Tropical Research (NWO-WOTRO) (The Netherlands)